Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | 3C20H24N2O2.2AsH3O4 |
| Molecular Weight | 1257.1363 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 12 / 12 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
O[As](O)(O)=O.O[As](O)(O)=O.[H][C@]1(C[C@@H]2CCN1C[C@@H]2C=C)[C@H](O)C3=C4C=C(OC)C=CC4=NC=C3.[H][C@]5(C[C@@H]6CCN5C[C@@H]6C=C)[C@H](O)C7=C8C=C(OC)C=CC8=NC=C7.[H][C@]9(C[C@@H]%10CCN9C[C@@H]%10C=C)[C@H](O)C%11=C%12C=C(OC)C=CC%12=NC=C%11
InChI
InChIKey=CDTYBBCOIQJQRO-INGJVHGESA-N
InChI=1S/3C20H24N2O2.2AsH3O4/c3*1-3-13-12-22-9-7-14(13)10-19(22)20(23)16-6-8-21-18-5-4-15(24-2)11-17(16)18;2*2-1(3,4)5/h3*3-6,8,11,13-14,19-20,23H,1,7,9-10,12H2,2H3;2*(H3,2,3,4,5)/t3*13-,14-,19-,20+;;/m000../s1
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Inorganic and methylated arsenic compounds induce cell death in murine macrophages via different mechanisms. | 1998 Apr |
|
| Purine nucleoside phosphorylase as a cytosolic arsenate reductase. | 2002 Nov |
|
| Genetic variation in genes associated with arsenic metabolism: glutathione S-transferase omega 1-1 and purine nucleoside phosphorylase polymorphisms in European and indigenous Americans. | 2003 Aug |
|
| Valproate-induced neural tube defects in folate-binding protein-2 (Folbp2) knockout mice. | 2003 Dec |
|
| Arsenite and arsenate activate extracellular signal-regulated kinases 1/2 by an epidermal growth factor receptor-mediated pathway in normal human keratinocytes. | 2003 Dec |
|
| Arsenic induced inhibition of delta-aminolevulinate dehydratase activity in rat blood and its response to meso 2,3-dimercaptosuccinic acid and monoisoamyl DMSA. | 2004 Mar |
|
| Regulation of cytoplasmic stress granules by apoptosis-inducing factor. | 2004 Sep 1 |
Patents
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
CFR |
21 CFR 310.547
Created by
admin on Fri Dec 15 15:48:19 GMT 2023 , Edited by admin on Fri Dec 15 15:48:19 GMT 2023
|
||
|
NCI_THESAURUS |
C271
Created by
admin on Fri Dec 15 15:48:19 GMT 2023 , Edited by admin on Fri Dec 15 15:48:19 GMT 2023
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
208-971-4
Created by
admin on Fri Dec 15 15:48:19 GMT 2023 , Edited by admin on Fri Dec 15 15:48:19 GMT 2023
|
PRIMARY | |||
|
C90738
Created by
admin on Fri Dec 15 15:48:19 GMT 2023 , Edited by admin on Fri Dec 15 15:48:19 GMT 2023
|
PRIMARY | |||
|
DTXSID70970226
Created by
admin on Fri Dec 15 15:48:19 GMT 2023 , Edited by admin on Fri Dec 15 15:48:19 GMT 2023
|
PRIMARY | |||
|
8C15XFK30P
Created by
admin on Fri Dec 15 15:48:19 GMT 2023 , Edited by admin on Fri Dec 15 15:48:19 GMT 2023
|
PRIMARY | |||
|
549-59-7
Created by
admin on Fri Dec 15 15:48:19 GMT 2023 , Edited by admin on Fri Dec 15 15:48:19 GMT 2023
|
PRIMARY | |||
|
8C15XFK30P
Created by
admin on Fri Dec 15 15:48:19 GMT 2023 , Edited by admin on Fri Dec 15 15:48:19 GMT 2023
|
PRIMARY | |||
|
20841765
Created by
admin on Fri Dec 15 15:48:19 GMT 2023 , Edited by admin on Fri Dec 15 15:48:19 GMT 2023
|
PRIMARY | |||
|
1309255
Created by
admin on Fri Dec 15 15:48:19 GMT 2023 , Edited by admin on Fri Dec 15 15:48:19 GMT 2023
|
PRIMARY | RxNorm |
ACTIVE MOIETY
PARENT (SALT/SOLVATE)
SUBSTANCE RECORD
